• Client Login
Ozmosi
  • Services
    • BEAM Clinical Trial Data
    • GCT Global Clinical Trials
    • PRYZM Pharma Product Database
    • KRYSTL Industry Scan Reporting
    • LENZ Company Pipeline Summary
    • Specialized Consulting
    • Approved Pharmaceutical Products in Use
  • About Us
  • Case Studies
  • Newsroom
  • Conference Info
  • Contact Us
Select Page
What do the big players have in store for the Diabetes market in the next 12 months?

What do the big players have in store for the Diabetes market in the next 12 months?

Oct 27, 2020 | Chronic Disease, Diabetes, Disease Area Trends

Diabetes is one of the most prevalent diseases in the U.S., afflicting over 29 million people across Type 1 and Type 2 patients, according to the CDC1 and represents over a $50 billion dollar industry2. Pharmaceutical companies are constantly racing to create the next...
Covid-19 Clinical Trials and Where to Get Treated Update

Covid-19 Clinical Trials and Where to Get Treated Update

Oct 20, 2020 | COVID-19, Disease Area Trends

Here is a quick update on the ever-evolving world of COVID-19 trials.  Since our initial posting on this topic three weeks ago, the number of trials has grown from 100 to over 300. The number of clinical facilities with clinical trials for COVID-19 has grown from 160...
Next Entries »

Recent Posts

  • Pharmaceutical Portfolio Strategy in the AI Era: Why External Intelligence MattersApril 29, 2026
  • Why AI Stalls in Pharmaceutical R&D Operations (and How to Fix It)March 31, 2026
  • Who is Winning in Innovation and How are They Balancing Risk?February 28, 2026
  • How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%January 16, 2026
  • Market Overview: GLP-1 Agonists and the Obesity MarketDecember 16, 2025
  • Not Your Grandparents’ Probability of Success ForecastsNovember 9, 2025
  • Home
  • About Us
  • Services
  • Case Studies
  • Newsroom
  • Contact Us
  • Facebook
  • X
OZMOSI© 2025 | All Rights Reserved | Site by Webtyde